19
February
2017


Share on networks

  • The French multinational corporation has chosen the city of Barcelona for its global Shift project
  • Catalonia is one of the favorite destinations for investment in the pharmaceutical sector in Europe

French multination pharmaceutical company Sanofi has chosen the city of Barcelona as the headquarters of its global Shift project. This initiative is creating a new department to redesign and unify the financial management tools used by all of the company’s subsidiaries. Located in the neighborhood of Sant Andreu, this center will employ 200 people when at full capacity.

Sanofi has an important presence in Spain, where it employs nearly 1,000 people. Its central headquarters is in Barcelona and it has an industrial center in Riells i Viabrea, Girona. The company is firmly committed to R&D activity, which it carries out through its Clinical Study Unit (CSU) with headquarters in Barcelona and Madrid.

The Sanofi group is one of the largest pharmaceutical groups in the world. It is based in Paris and present in more than 100 countries. It employs more than 110,000 people around the world and has 107 factories and over 20 R&D centers in North America, Asia and Europe.

Catalonia, which is home to 45% of Spain’s pharmaceutical activity, has traditionally been one of the favorite destinations for investment in the pharmaceutical sector in Europe. There are more than 72,000 people working at nearly 600 companies in the sector and more than 100 research groups working in this area. They have chosen to do so mainly due to the competitive R&D system and network of research centers and science and technology parks.

[02/22/2017]

Share on networks

Related news

Llum verda a l’ampliació de l’aeroport del Prat: una inversió de 3.200 milions d’euros per assolir els 70 milions de passatgers

News

El Prat airport expansion gets green light: €3.2 billion to be invested to reach 70 million passengers

Barcelona, entre el ‘top cinc’ dels principals hubs de startups de la Unió Europea per segon any consecutiu

News

Barcelona among top five start-up hubs in European Union for second year in a row

El nou Campus Barcelona de Smith+Nephew consolida Catalunya com a referent de la innovació sanitària a Europa

News

New Smith+Nephew Barcelona Campus consolidates Catalonia as European benchmark in healthcare innovation

Les ciències de la vida a Catalunya es consoliden com a eix d’innovació i creixement: 220 milions d’inversió i 8,7% del PIB

News

Consolidation of life sciences in Catalonia as driving force for innovation and growth: €220 million invested and 8.7% of GDP

Barcelona Catalonia
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.